These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32574144)

  • 1. Surveillance post-radiofrequency ablation for small renal masses: Recurrence and followup.
    Lam CJ; Wong NC; Voss M; Mironov O; Connolly M; Matsumoto ED; Kapoor A
    Can Urol Assoc J; 2020 Dec; 14(12):398-403. PubMed ID: 32574144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
    Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
    Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
    Ma Y; Bedir S; Cadeddu JA; Gahan JC
    BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation versus partial nephrectomy for the treatment of clinical stage 1 renal masses: a systematic review and meta-analysis.
    Wang S; Qin C; Peng Z; Cao Q; Li P; Shao P; Ju X; Meng X; Lu Q; Li J; Wang M; Zhang Z; Gu M; Zhang W; Yin C
    Chin Med J (Engl); 2014; 127(13):2497-503. PubMed ID: 24985591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.
    Cooper CJ; Teleb M; Dwivedi A; Rangel G; Sanchez LA; Laks S; Akle N; Nahleh Z
    Rare Tumors; 2015 Feb; 7(1):5583. PubMed ID: 25918603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.
    Varkarakis IM; Allaf ME; Inagaki T; Bhayani SB; Chan DY; Su LM; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2005 Aug; 174(2):456-60; discussion 460. PubMed ID: 16006864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
    Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.
    Kunkle DA; Uzzo RG
    Cancer; 2008 Nov; 113(10):2671-80. PubMed ID: 18816624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
    Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
    Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring.
    Wingo MS; Leveillee RJ
    J Endourol; 2008 Jun; 22(6):1261-7. PubMed ID: 18484892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
    Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
    Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.